Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert J Sims

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Plos One|March 30, 2022
CREBBP/EP300 acetyltransferase inhibition disrupts FOXA1-bound enhancers to inhibit the proliferation of ER+ breast cancer cellsArchana Bommi-Reddy, Sungmi Park-Chouinard, David N Mayhew, et al.
Molecular Cell|April 7, 2015
ATR-mediated phosphorylation of FANCI regulates dormant origin firing in response to replication stressYu-Hung Chen, Mathew J K Jones, Yandong Yin, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 18, 2012
BRD4 is an atypical kinase that phosphorylates serine2 of the RNA polymerase II carboxy-terminal domainBallachanda N Devaiah, Brian A Lewis, Natasha Cherman, et al.
Fluids and Barriers of the CNS|August 17, 2018
Accurate, strong, and stable reporting of choroid plexus epithelial cells in transgenic mice using a human transthyretin BACBrett A Johnson, Margaret Coutts, Hillary M Vo, et al.
Cell|June 2, 2007
L3MBTL1, a histone-methylation-dependent chromatin lockPatrick Trojer, Guohong Li, Robert J Sims, et al.
Nature Structural & Molecular Biology|April 27, 2007
FANCI is a second monoubiquitinated member of the Fanconi anemia pathwayAshley E Sims, Elizabeth Spiteri, Robert J Sims, et al.
ACS Medicinal Chemistry Letters|June 20, 2020
Discovery of CPI-1612: A Potent, Selective, and Orally Bioavailable EP300/CBP Histone Acetyltransferase InhibitorJonathan E Wilson, Gaurav Patel, Chirag Patel, et al.
Cancer Research|January 14, 2016
Preclinical Anticancer Efficacy of BET Bromodomain Inhibitors Is Determined by the Apoptotic ResponseAndrew R Conery, Richard C Centore, Kerry L Spillane, et al.
Nature Genetics|March 30, 2002
Bop encodes a muscle-restricted protein containing MYND and SET domains and is essential for cardiac differentiation and morphogenesisPaul D Gottlieb, Stephanie A Pierce, Robert J Sims, et al.
Elife|January 6, 2016
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myelomaAndrew R Conery, Richard C Centore, Adrianne Neiss, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Plos One|March 30, 2022
CREBBP/EP300 acetyltransferase inhibition disrupts FOXA1-bound enhancers to inhibit the proliferation of ER+ breast cancer cellsArchana Bommi-Reddy, Sungmi Park-Chouinard, David N Mayhew, et al.
Molecular Cell|April 7, 2015
ATR-mediated phosphorylation of FANCI regulates dormant origin firing in response to replication stressYu-Hung Chen, Mathew J K Jones, Yandong Yin, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 18, 2012
BRD4 is an atypical kinase that phosphorylates serine2 of the RNA polymerase II carboxy-terminal domainBallachanda N Devaiah, Brian A Lewis, Natasha Cherman, et al.
Fluids and Barriers of the CNS|August 17, 2018
Accurate, strong, and stable reporting of choroid plexus epithelial cells in transgenic mice using a human transthyretin BACBrett A Johnson, Margaret Coutts, Hillary M Vo, et al.
Cell|June 2, 2007
L3MBTL1, a histone-methylation-dependent chromatin lockPatrick Trojer, Guohong Li, Robert J Sims, et al.
Nature Structural & Molecular Biology|April 27, 2007
FANCI is a second monoubiquitinated member of the Fanconi anemia pathwayAshley E Sims, Elizabeth Spiteri, Robert J Sims, et al.
ACS Medicinal Chemistry Letters|June 20, 2020
Discovery of CPI-1612: A Potent, Selective, and Orally Bioavailable EP300/CBP Histone Acetyltransferase InhibitorJonathan E Wilson, Gaurav Patel, Chirag Patel, et al.
Cancer Research|January 14, 2016
Preclinical Anticancer Efficacy of BET Bromodomain Inhibitors Is Determined by the Apoptotic ResponseAndrew R Conery, Richard C Centore, Kerry L Spillane, et al.
Nature Genetics|March 30, 2002
Bop encodes a muscle-restricted protein containing MYND and SET domains and is essential for cardiac differentiation and morphogenesisPaul D Gottlieb, Stephanie A Pierce, Robert J Sims, et al.
Elife|January 6, 2016
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myelomaAndrew R Conery, Richard C Centore, Adrianne Neiss, et al.
Pageof 5